April 25, 2023
Experience sparks patient’s passion for helping others
Janine Jones has one mission in her life – to be a voice for fellow cancer patients, helping others navigate their cancer journeys.
Tag: Lymphoma Clinical Program
July 23, 2021
Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa
Matthew Painschab, MD, and colleagues report that a five-drug combination chemotherapy provided curative benefit in people diagnosed with diffuse large B-cell lymphoma and is also a cost-effective option in Malawi.
August 25, 2020
NCI grant funds UNC-led consortium studying HIV-related cancers in sub-Saharan Africa
A team of UNC researchers are partnering with colleagues at three institutions in Africa to study HIV-associated malignancies: Kaposi sarcoma, cervical cancer and lymphoma.
June 17, 2020
MedPage Today: Clinical Challenges: Relapsed Hodgkin’s After Transplant
January 14, 2020
Dittus and colleagues write the book on rare lymphomas
UNC Lineberger’s Christopher Dittus, DO, MPH, assistant professor of medicine at UNC School of Medicine, is the editor of a new book that provides a comprehensive review of how to diagnose and manage rare lymphomas, with a focus on novel treatment approaches. UNC Lineberger faculty and trainees contributed chapters to the volume. “Novel Therapeutics for …
September 3, 2019
Leukemia & Lymphoma Society grant supports drug discovery research
The Leukemia & Lymphoma Society has awarded a $971,484 Screen to Lead grant to University of North Carolina Lineberger Comprehensive Cancer Center researchers to launch an investigation of new drug compounds that would block enzymes that can become hyperactive in blood cancer cells when mutated. UNC Lineberger’s John Sondek, PhD, a professor in the UNC …
January 2, 2019
Oncology Times: Genetically Engineered Immune Cells Fight Relapsed Blood Cancer
October 29, 2018
Former patient donates $10 million to further blood cancer research at UNC Lineberger
Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, will create a new fund supporting ground-breaking research in blood cancer at UNC Lineberger Comprehensive Cancer Center, including lymphoma, leukemia and myeloma research, in gratitude for the care Champ received and to bolster research directed at finding cures.
July 23, 2018
UNC Lineberger lymphoma conference draws experts from North Carolina and Virginia
A range of specialties, including oncology, pathology, nursing and pharmacy, represented at meeting developed to promote discussions about lymphoma cases, share insights and plan ways to collaborate more effectively in regional, multicenter clinical trials.
February 28, 2017
UNC Lineberger launches innovative cellular immunotherapy program
UNC Lineberger, with its U.S. FDA-approved Good Manufacturing Practices, or “clean,” facility, is one of only a select academic centers in the United States with the capability to genetically modify patient immune cells for clinical use. This makes it possible for people who live in the Southeastern U.S. to stay closer to home to undergo cellular immunotherapy treatment.